Evid Based Nurs 11:117 doi:10.1136/ebn.11.4.117
  • Treatment

Review: low-molecular-weight heparin prevented recurrent VTE more than oral anticoagulants in patients with cancer

E A Akl

Dr E A Akl, State University of New York at Buffalo, Buffalo, NY, USA;


In patients with cancer and venous thromboembolism (VTE), is long-term treatment with low-molecular-weight heparin (LMWH) effective and safe compared with oral anticoagulants?


Studies selected compared LMWH with oral anticoagulants (vitamin K antagonists or ximelagatran) for long-term treatment in patients with cancer and objectively diagnosed VTE. Outcomes were mortality, symptomatic recurrent VTE, major bleeding, and thrombocytopenia.


Cochrane Central Register of Controlled Trials, Medline, EMBASE/Excerpta Medica, and ISI the Web of Science (to Jan 2007); conference proceedings; reference lists; and the “related articles” feature of PubMed were searched for randomised controlled trials (RCTs). …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article